Literature DB >> 26487569

Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis.

Anne Platel1,2,3, Rodolphe Carpentier4,5, Elodie Becart1,2, Gwendoline Mordacq1,2, Didier Betbeder1,4,5, Fabrice Nesslany1,2,3.   

Abstract

With the ongoing commercialization of nanotechnology products, human exposure to nanoparticles (NPs) is set to increase dramatically and an evaluation of their potential adverse effects is essential. Surface charge, among other physico-chemicals parameters, is a key criterion that should be considered when using a definition for nanomaterials in a regulatory context. It has recently been recognized as an important factor in determining the toxicity of NPs; however, a complete understanding of the mechanisms involved is still lacking. In this context, the aim of the present study was to investigate the influence of the surface charge modification of NPs on in vitro toxicity assays. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles bearing different surface charges, positive(+), neutral(n) or negative(-), were synthesized. In vitro genotoxicity assays (micronucleus and comet assays) coupled with an assessment of cytotoxicity, were performed in different cell lines (L5178Y mouse lymphoma cells, TK6 human B-lymphoblastoid cells and 16HBE14o- human bronchial epithelial cells). Reactive oxygen species (ROS) production and endocytosis studies were also performed. Our results showed that PLGA(+) NPs were cytotoxic. They are endocytosed by the clathrin pathway and induced ROS in the three cell lines. They led to chromosomal aberrations without primary DNA damage in 16HBE14o- cells, suggesting that aneuploidy may be considered as an important biomarker when assessing the genotoxic potential of NPs. Moreover, 16HBE14o- cells seem to be more suitable for the in vitro screening of inhaled NPs than the regulatory L5178Y and TK6 cells.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  16HBE14o- human bronchial epithelial cells; L5178Y mouse lymphoma cells; ROS; TK6 human lymphoblastoid cells; endocytosis; genotoxicity, cytotoxicity; nanoparticles of PLGA

Mesh:

Substances:

Year:  2015        PMID: 26487569     DOI: 10.1002/jat.3247

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  15 in total

1.  Inhibition of high shear arterial thrombosis by charged nanoparticles.

Authors:  Michael T Griffin; Yuanzheng Zhu; Zixiang Liu; Cyrus K Aidun; David N Ku
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

2.  Trends in the Design and Evaluation of Polymeric Nanocarriers: The In Vitro Nano-Bio Interactions.

Authors:  Ana Bettencourt; Lídia M Gonçalves
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Uptake and intracellular accumulation of diamond nanoparticles - a metabolic and cytotoxic study.

Authors:  Antonín Brož; Lucie Bačáková; Pavla Štenclová; Alexander Kromka; Štěpán Potocký
Journal:  Beilstein J Nanotechnol       Date:  2017-08-10       Impact factor: 3.649

4.  Vectorization by nanoparticles decreases the overall toxicity of airborne pollutants.

Authors:  Rodolphe Carpentier; Anne Platel; Helena Maiz-Gregores; Fabrice Nesslany; Didier Betbeder
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

5.  Effect of physicochemical character differences on the genotoxic potency of kaolin.

Authors:  Tatsuya Kato; Tatsushi Toyooka; Yuko Ibuki; Shuichi Masuda; Masatoshi Watanabe; Yukari Totsuka
Journal:  Genes Environ       Date:  2017-05-01

6.  In vitro toxicity studies of biodegradable, polyelectrolyte nanocapsules.

Authors:  Alicja Karabasz; Krzysztof Szczepanowicz; Agnieszka Cierniak; Joanna Bereta; Monika Bzowska
Journal:  Int J Nanomedicine       Date:  2018-09-06

Review 7.  Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell.

Authors:  Darío Manzanares; Valentín Ceña
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

Review 8.  Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.

Authors:  Sandra Jesus; Mélanie Schmutz; Claudia Som; Gerrit Borchard; Peter Wick; Olga Borges
Journal:  Front Bioeng Biotechnol       Date:  2019-10-23

9.  Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability.

Authors:  Ruba Ismail; Alexandra Bocsik; Gábor Katona; Ilona Gróf; Mária A Deli; Ildikó Csóka
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

10.  PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment.

Authors:  Ana I Fraguas-Sánchez; Ana I Torres-Suárez; Marie Cohen; Florence Delie; Daniel Bastida-Ruiz; Lucile Yart; Cristina Martin-Sabroso; Ana Fernández-Carballido
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.